TR200505223T2 - Azaltılmış yan etkileri olan uzun süreli salınımlı tiagabin formülasyonları. - Google Patents

Azaltılmış yan etkileri olan uzun süreli salınımlı tiagabin formülasyonları.

Info

Publication number
TR200505223T2
TR200505223T2 TR2005/05223T TR200505223T TR200505223T2 TR 200505223 T2 TR200505223 T2 TR 200505223T2 TR 2005/05223 T TR2005/05223 T TR 2005/05223T TR 200505223 T TR200505223 T TR 200505223T TR 200505223 T2 TR200505223 T2 TR 200505223T2
Authority
TR
Turkey
Prior art keywords
side effects
long
reduced side
term release
formulations
Prior art date
Application number
TR2005/05223T
Other languages
English (en)
Inventor
J. Alvarez Francisco
T. Slade Russell
M. Apfelbaum Kathleen
M. Brown David
E. Gustavson Linda
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of TR200505223T2 publication Critical patent/TR200505223T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bir hastaya uygulandığında daha az yan etki gösteren uzun süreli salınımlı tiagabin formülasyonlarıdır.
TR2005/05223T 1998-01-22 1999-01-22 Azaltılmış yan etkileri olan uzun süreli salınımlı tiagabin formülasyonları. TR200505223T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7213098P 1998-01-22 1998-01-22

Publications (1)

Publication Number Publication Date
TR200505223T2 true TR200505223T2 (tr) 2006-04-21

Family

ID=22105780

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2000/02102T TR200002102T2 (tr) 1998-01-22 1999-01-22 Azaltılmış yan etkileri olan uzun süreli salınımlı tiagabin formülasyonları
TR2005/05223T TR200505223T2 (tr) 1998-01-22 1999-01-22 Azaltılmış yan etkileri olan uzun süreli salınımlı tiagabin formülasyonları.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2000/02102T TR200002102T2 (tr) 1998-01-22 1999-01-22 Azaltılmış yan etkileri olan uzun süreli salınımlı tiagabin formülasyonları

Country Status (23)

Country Link
US (1) US20070053980A1 (tr)
EP (1) EP1049470B1 (tr)
JP (1) JP2002501022A (tr)
KR (1) KR20010034313A (tr)
CN (1) CN1145484C (tr)
AR (1) AR018041A1 (tr)
AT (1) ATE350035T1 (tr)
AU (1) AU2239599A (tr)
BG (1) BG104692A (tr)
CA (1) CA2318448A1 (tr)
CO (1) CO4970814A1 (tr)
DE (1) DE69934670D1 (tr)
HU (1) HUP0101739A3 (tr)
IL (1) IL137324A0 (tr)
NO (1) NO20003677L (tr)
NZ (1) NZ505725A (tr)
PL (1) PL194595B1 (tr)
SA (1) SA99200204B1 (tr)
SK (1) SK11072000A3 (tr)
TR (2) TR200002102T2 (tr)
TW (1) TW585787B (tr)
WO (1) WO1999037302A1 (tr)
ZA (1) ZA99407B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872734B2 (en) 2000-10-20 2005-03-29 Abbott Laboratories Use of tiagabine for treatment of diabetic neuropathy and migraine
KR100510270B1 (ko) * 2002-11-29 2005-08-26 센츄론(주) 펠렛타이저를 이용한 서방성 제제의 제조방법
CN102908327B (zh) * 2011-08-05 2015-03-11 江苏恒瑞医药股份有限公司 伊伐布雷定或其可药用盐的缓释制剂
KR102051132B1 (ko) * 2017-03-17 2019-12-02 주식회사 종근당 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
US5126145A (en) * 1989-04-13 1992-06-30 Upsher Smith Laboratories Inc Controlled release tablet containing water soluble medicament
US5273758A (en) * 1991-03-18 1993-12-28 Sandoz Ltd. Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
CZ292256B6 (cs) * 1995-05-05 2003-08-13 Novo Nordisk A/S Farmaceutická směs a způsob její přípravy
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
PT991409E (pt) * 1997-08-01 2002-06-28 Elan Corp Plc Composicoes farmaceuticas de libertacao controlada contendo tiagabina
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting

Also Published As

Publication number Publication date
AR018041A1 (es) 2001-10-31
SA99200204B1 (ar) 2006-10-11
TW585787B (en) 2004-05-01
KR20010034313A (ko) 2001-04-25
IL137324A0 (en) 2001-07-24
NO20003677L (no) 2000-09-20
CO4970814A1 (es) 2000-11-07
US20070053980A1 (en) 2007-03-08
ZA99407B (en) 1999-07-20
PL342767A1 (en) 2001-07-02
AU2239599A (en) 1999-08-09
DE69934670D1 (de) 2007-02-15
BG104692A (en) 2001-05-31
HUP0101739A2 (hu) 2002-03-28
EP1049470A1 (en) 2000-11-08
CN1145484C (zh) 2004-04-14
PL194595B1 (pl) 2007-06-29
SK11072000A3 (sk) 2001-01-18
ATE350035T1 (de) 2007-01-15
WO1999037302A1 (en) 1999-07-29
CN1293571A (zh) 2001-05-02
NO20003677D0 (no) 2000-07-18
EP1049470B1 (en) 2007-01-03
HUP0101739A3 (en) 2002-10-28
CA2318448A1 (en) 1999-07-29
NZ505725A (en) 2003-01-31
JP2002501022A (ja) 2002-01-15
TR200002102T2 (tr) 2000-12-21

Similar Documents

Publication Publication Date Title
DE60042904D1 (de) Orale Dosiszusammensetzung mit verlängerter Freigabe
HN1999000066A (es) Formulaciones farmaceuticas
ID29031A (id) Piperidin sebagai modulator ccr5
DK1223997T3 (da) Medicinsk infusionssæt
IT1320164B1 (it) Sistema di aterectomia rotazionale con punta di taglio a denti disega.
ATE360032T1 (de) Cystein-reiche rezeptoren-train
NO20014834D0 (no) Tannprotese adhesive sammensetninger
TR200101783T2 (tr) Saydam transdermal nikotin iletme düzenekleri.
TR200505223T2 (tr) Azaltılmış yan etkileri olan uzun süreli salınımlı tiagabin formülasyonları.
BR9907195A (pt) " formulações de tiagabina de liberação prolongada com efeitos colaterais reduzidos "
IT1307933B1 (it) Guida per cassetti con apertura frenata.
IT1310385B1 (it) Dispositivo per migliorare la respirazione.
ES1041163Y (es) Protector labial.
NO20014833L (no) Tannprotese adhesive sammensetninger
ITMO990002A0 (it) Articolatore per odontotecnica.
ITRM990147V0 (it) Bavagliolo per uso dentistico con linguetta adesiva attaccata.
IT1306218B1 (it) Dispositivo ortodontico per spostare denti.
ITRM980227U1 (it) Il dolor-stop odontoiatrico: meccanismo per il controllo/gestione del dolore in odontoiatria.
FR2790382B1 (fr) Articulateur dentaire
ITBO980581A0 (it) Siringa odontoiatrica .
HN1998000145A (es) Formulaciones parasiticidas
ES1039256Y (es) Guia para cajones perfeccionada.
FI4419U1 (fi) Selän hoitolaite
ITFI20000036V0 (it) Vite ad espansione tridirezionale per apparecchi ortodontici da applicarsi all'arcata dentaria inferiore
IT1297667B1 (it) Dispositivo per la costruzione di apparecchi ortodontici per spostare denti.